The relationship between different types of primary glaucoma and retinal vein occlusion ; Взаимосвязь между различными формами первичной глаукомы и ретинальной венозной окклюзией

Συγγραφείς: A. B. Galimova, A. V. Kuroyedov, V. U. Galimova, А. Б. Галимова, А. В. Куроедов, В. У. Галимова

Πηγή: National Journal glaucoma; Том 23, № 3 (2024); 54-66 ; Национальный журнал Глаукома; Том 23, № 3 (2024); 54-66 ; 2311-6862 ; 2078-4104

Θεματικοί όροι: анти-VEGF терапия, primary angle-closure glaucoma, retinal vein occlusion, central retinal vein occlusion, anti-VEGF therapy, первичная закрытоугольная глаукома, ретинальная венозная окклюзия, окклюзия центральной вены сетчатки

Περιγραφή αρχείου: application/pdf

Relation: https://www.glaucomajournal.ru/jour/article/view/536/479; Klein R., Moss S.E., Meuer S.M., Klein B.E. The 15-year cumulative incidence of retinal vein occlusion: the Beaver Dam Eye Study. Arch Ophthalmol 2008; 126:513-518. https://doi.org/10.1001/archopht.126.4.513; Rogers S., McIntosh R.L., Cheung N., Lim L., et al. The prevalence of retinal vein occlusion: pooled data from the United States, Europe, Asia and Australia. Ophthalmology 2010; 117:313-319. https://doi.org/10.1016/j.ophtha.2009.07.017; Hayreh S.S., Zimmerman M.B., Podhajsky P. Incidence of various types of retinal vein occlusion and their recurrence and demographic characteristics. Am J Ophthalmol 1994; 117:429-441. https://doi.org/10.1016/s0002-9394(14)70001-7; Cheung N., Klein R., Wang J.J., Cotch M.F., et al. Traditional and novel cardiovascular risk factors for retinal vein occlusion: the multiethnic study of atherosclerosis. Invest Ophthalmol Vis Sci 2008; 49: 4297-4302. https://doi.org/10.1167/iovs.08-1826; Stem M.S., Talwar N., Comer G.M., Stein J.D. A longitudinal analysis of risk factors associated with central retinal vein occlusion. Ophthalmology 2013; 120:362-370. https://doi.org/10.1016/j.ophtha.2012.07.080; Gaba W.H., Ahmed D., Al Nuaimi R.K., Dhanhani A.A., et al. Bilateral central retinal vein occlusion in a 40-year-old man with severe coronavirus disease 2019 (COVID-19) pneumonia. Am J Case Rep 2020; 21:e927691. https://doi.org/10.12659/AJCR.927691; Kapataeyes N., Joondeph B. Retinal vein occlusion associated with Covid-19. Retina Today 2020; 9:32-33.; Sen M., Honavar S.G., Sharma N., Sachdev M.S. COVID-19 and Eye: A review of ophthalmic manifestations of COVID-19. Indian J Ophthalmol 2021; 69(3):488-509. https://doi.org/10.4103/ijo.IJO_297_21; Walinjkar J.A., Makhija S.C., Sharma H.R., Morekar S.R., et al. Central retinal vein occlusion with COVID-19 infection as the presumptive etiology. Indian J Ophthalmol 2020; 68(11):2572-2574. https://doi.org/10.4103/ijo.IJO_2575_20; Sheth J.U., Narayanan R., Goyal J., Goyal V. Retinal vein occlusion in COVID-19. Indian Journal of Ophthalmology 2020; 68(10):2291-2293.; Quigley H.A., Broman A.T. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol 2006; 90:262-267. https://doi.org/10.1136/bjo.2005.081224; Tham Y.C., Li X., Wong T.Y., Quigley H.A., et al. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology 2014; 121:2081- 2090. https://doi.org/10.1016/j.ophtha.2014.05.013; Нестеров А.П. Глаукома: основные проблемы, новые возможности. Вестник офтальмологии 2008; 124 (1):3-7.; Grzybowski A., Och M., Kanclerz P., Leffler C., et al. Primary Open Angle Glaucoma and Vascular Risk Factors: A Review of Population Based Studies from 1990 to 2019. J Clin Med 2020; 9(3):761. https://doi.org/10.3390/jcm9030761.; European Glaucoma Society Terminology and Guidelines for Glaucoma, 4th Edition – Chapter 2: Classification and terminology Supported by the EGS Foundation: Part 1: Foreword; Introduction; Glossary; Chapter 2 Classification and Terminology. Br J Ophthalmol 2017; 101(5):73-127. https://doi.org/10.1136/bjophthalmol-2016-EGSguideline.002.; Yanagi M., Kawasaki R., Wang J.J., Wong T.Y., et al. Vascular risk factors in glaucoma: a review. Clin Exp Ophthalmol 2011; 39(3):252-258. https://doi.org/10.1111/j.1442-9071.2010.02455.x.; Eye Disease Case-Control Study Group. Risk factors for branch retinal vein occlusion. Am J Ophthalmol 1993; 116:286-296.; Eye Disease Case-Control Study Group. Risk factors for central retinal vein occlusion. Arch Ophthalmol 1996; 114:545-554.; Mitchell P., Smith W., Chang A. Prevalence and association of retinal vein occlusion in Australia: The Blue Mountains Eye Study. Arch Ophthalmol 1996; 114:1243-1247. https://doi.org/10.1001/archopht.1996.01100140443012; Cugati S., Wang J.J., Rochtchina E., Mitchell P. Ten-year incidence of retinal vein occlusion in an older population: the Blue Mountains Eye Study. Arch Ophthalmol 2006; 124:726-732. https://doi.org/10.1001/archopht.124.5.726; Thapa R., Paudyal G., Bernstein P.S. Demographic characteristics patterns and risk factors for retinal vein occlusion in Nepal: a hospitalbased case-control study. Clin Exp Ophthalmol 2010; 38:583-590. https://doi.org/10.1111/j.1442-9071.2010.02295.x; Xu K., Wu L., Ma Z., Liu Y., et al. Primary angle closure and primary angle closure glaucoma in retinal vein occlusion. Acta Ophthalmol 2019; 97:e364-e372. https://doi.org/10.1111/aos.13879; Coscas G., Loewenstein A., Augustin A., Bandello F., et al. Management of retinal vein occlusion – Consensus document. Ophthalmologica 2011; 226:4-28. https://doi.org/10.1159/000327391; Haymore J.G., Mejico L.J. Retinal vascular occlusion syndromes. Int Ophthalmol Clin 2009; 49:63-79. https://doi.org/10.1097/IIO.0b013e3181a8db88; Green W.R., Chan C.C., Hutchins G.M., Terry J.M. Central retinal vein occlusion: a prospective histopathologic study of 29 eyes in 28 cases. Trans Am Ophthalmol Soc 1981; 79:371-422.; Frangieh G.T., Green W.R., Barraquer-Somers E., Finkelstein D. Histopathologic study of nine branch retinal vein occlusions. Arch of Ophthalmol 1982; 100(7):1132-1140. https://doi.org/10.1001/archopht.1982.01030040110020; Duker J.S., Brown G.C. Anterior location of crossing artery in branch retinal vein obstruction. Arch Ophthalmol 1989; 107(7):998-1000. https://doi.org/10.1001/archopht.1989.01070020060029; Christoffersen N.L., Larsen M. Pathophysiology and hemodynamics of branch retinal vein occlusion. Ophthalmology 1999; 106(11):2054- 2062. https://doi.org/10.1016/S0161-6420(99)90483-9; Paszkowiak J.J., Dardik A. Arterial wall shear stress: observations from the bench to the bedside. Vasc Endovascular Surg 2003; 37(1): 47-57. https://doi.org/10.1177/153857440303700107; Кански Д. Клиническая офтальмология: систематизированный подход. 2-е изд., под ред. В.П. Еричева. Wroclaw: Elsevier Urban& Partner 2009; 944.; Joussen A.M., Murata T., Tsujikawa A., Kirchhof B., et al. Leukocytemediated endothelial cell injury and death in diabetic retina. Am J Pathol 2001; 158:147-152. https://doi.org/10.1016/S0002-9440(10)63952-1; Тульцева С.Н., Астахов Ю.С. Роль воспаления в патогенезе посттромботического макулярного отека. Современные направления медикаментозного лечения. Офтальмологические ведомости 2012; 1(4):35-44.; Daurich A., Matet A., Moulin A., Kowalzcuk L., et al. Mechanisms of macular edema: Beyond the surface. Progress in Retinal and Eye Research 2018; 63:20-68. https://doi.org/10.1016/j.preteyeres.2017.10.006.; Yin X., Li L., Zhang B., Lu P. Association of glaucoma with risk of re-tinal vein occlusion: a meta-analysis. Acta Ophthalmol 2019; 97:652-659. https://doi.org/10.1111/aos.1414.; Klein R., Klein B.E., Moss S.E., Meuer S.M. The epidemiology of retinal vein occlusion: the Beaver Dam Eye Study. Trans Am Ophthalmol Soc 2000; 98:133-141.; Hirota A., Mishima H.K., Kiuchi Y. Incidence of retinal vein occlusion at the Glaucoma Clinic of Hiroshima University. Ophthalmologica 1997; 211(5):288-291. https://doi.org/10.1159/000310810.; Liu W., Xu L., Jonas J.B. Vein occlusion in Chinese subjects. Ophthalmology 2007; 114:1795-1796. https://doi.org/10.1016/j.ophtha.2007.03.010; Barnett E.M., Fantin A., Wilson B.S., Kass M.A., et al. Ocular Hypertension Treatment Study Group. The incidence of retinal vein occlusion in the ocular hypertension treatment study. Ophthalmology 2010; 117(3):484-488. https://doi.org/10.1016/j.ophtha.2009.08.022; Wittström E., Ponjavic V., Lövestam-Adrian M., Larsson J., et al. Electrophysiological evaluation and visual outcome in patients with central retinal vein occlusion, primary open-angle glaucoma and neovascular glaucoma. Acta Ophthalmol 2010; 88:86-90. https://doi.org/10.1111/j.1755-3768.2008.01424.x; Frucht J., Shapiro A., Merin S. Intraocular pressure in retinal vein occlusion. Br J Ophthalmol 1984; 68:26-28.; Klein B.E., Meuer S.M., Knudtson M.D., Klein R. The relationship of optic disk cupping to retinal vein occlusion: the Beaver Dam Eye Study. Am J Ophthalmol. 2006; 141:859-862. https://doi.org/10.1016/j.ajo.2005.12.015; Beaumont P.E., Kang H.K. Cup-to-disk ratio, intraocular pressure, and primary open-angle glaucoma in retinal venous occlusion. Ophthalmology 2002; 109:282-286. https://doi.org/10.1016/s0161-6420(01)00922-8; Jonas J.B., Berenshtein E., Holbach L. Anatomic relationship between lamina cribrosa, intraocular space and cerebrospinal fluid space. Invest Ophthalmol Vis Sci 2003; 44:5189-5195. https://doi.org/10.1167/iovs.03-0174; Sin B.H., Song B.J., Park S.P. Aqueous vascular endothelial growth factor and endothelin-1 levels in branch retinal vein occlusion associated with normal tension glaucoma. J Glaucoma 2013; 22(2):104-109. https://doi.org/10.1097/IJG.0b013e3182312047.; Park H-Y., Jeong H.J., Kim Y.H., Park C.K. Optic disc hemorrhage is related to various hemodynamic findings by disc angiography. PLoS One 2015; 10: e0120000. https://doi.org/10.1371/journal.pone.0120000.; Baek J., Jeon S.J., Kim J.H., Park C.K., et al. Optic Disc Vascular Density in Normal-Tension Glaucoma Eyes with or without Branch Retinal Vessel Occlusion. J Clin Med 2021; 10(12):2574. https://doi.org/10.3390/jcm10122574.; Na K.I., Jeoung J.W., Kim Y.K., Lee W.J., et al. Incidence of Open-angle Glaucoma in Newly Diagnosed Retinal Vein Occlusion: A Nationwide Population-based Study. J Glaucoma 2019; 28(2):111-118. https://doi.org/10.1097/IJG.0000000000001134; Park H-Y., Jung Y., Han K., Lee M.Y., et al. Health care claims for primary open-angle glaucoma and retinal vein occlusion from an 11-year nationwide dataset. Scientific reports 2017; 7:8038. https://doi.org/10.1038/s41598-017-07890-6.; Park H-Y., Jeon S., Lee M.Y., Park C.K. Glaucoma progression in the unaffected fellow eye of glaucoma patients who developed unilateral branch retinal vein occlusion. Am J Ophthalmol 2017; 175:194-200. https://doi.org/10.1016/j.ajo.2016.10.009.; Shin Y.I., Nam K.Y., Lee S.E., Lim H-B., et al. Changes in Peripapillary Microvasculature and Retinal Thickness in the Fellow Eyes of Patients With Unilateral Retinal Vein Occlusion: An OCTA Study. Invest Ophthalmol Vis Sci 2019; 60(2):823-829. https://doi.org/10.1167/iovs.18-26288.; Fan L., Zhu Y., Sun X., Yu J., et al. Patients with unilateral retinal vein occlusion show reduced radial peripapillary capillary density in their fellow eyes. BMC Ophthalmol 2021; 21:448-456. https://doi.org/10.1186/s12886-021-02192-y.; Wang X., Jiang C., Ko T., Kong X., et al. Correlation between optic disc perfusion and glaucomatous severity in patients with open-angle glaucoma: an optical coherence tomography angiography study. Graefes Arch Clin Exp Ophthalmol 2015; 253(9):1557-1564. https://doi.org/10.1007/s00417-015-3095-y.; Курышева Н.И., Маслова Е.В., Трубилина А.В. Снижение перипапиллярного кровотока как фактор развития и прогрессирования первичной открытоугольной глаукомы. Российский офтальмологический журнал 2016; 3:34-41. https://doi.org/10.21516/2072-0076-2016-9-3-34-41.; Юрьева Т.Н., Жукова С.И. ОКТ-ангиография в комплексной оценке эффективности гипотензивной терапии у больных с первичной открытоугольной глаукомой. Российский офтальмологический журнал 2019; 12(3):43-49. https://doi.org/10.21516/2072-0076-2019-12-3-43-49.; Курышева Н.И. ОКТ-ангиография и ее роль в исследовании ретинальной микроциркуляции при глаукоме (часть вторая). Российский офтальмологический журнал 2018; 11(3):95-100. https://doi.org/10.21516/2072-0076-2018-11-3-95-100.; Rao H.L., Pradhan Z.S., Weinreb RN., Reddy H.B., et al. Regional comparisons of optical coherence tomography angiography vessel density in primary open-angle glaucoma. Am J Ophthalmol 2016; 171:75-83. https://doi.org/10.1016/j.ajo.2016.08.030.; Kurysheva N.I. Macula in glaucoma: vascularity evaluated by OCT angiography. Res J Pharmaceutical, Biological and Chemical Sci 2016; 7(5):651-662.; Michaelides M., Foster P.J. Retinal vein occlusion and angle closure: a retrospective case series. J Glaucoma 2010; 19:643-649. https://doi.org/10.1097/IJG.0b013e3181d12dea; Mohammadi M., Bazvand F., Makateb A., Eslami Y., et al. Comparison of anterior segment optical coherence tomography parameters between central retinal vein occlusion and normal eyes: is primary angle closure a risk factor for central retinal vein occlusion? Retina 2015; 35(9):1795-1799. https://doi.org/10.1097/IAE.0000000000000549.; Wu S.C., Lee Y.S., Wu W.C., Chang S.H. Anterior chamber depth and angle-closure glaucoma after central retinal vein occlusion. BMC Ophthalmol 2016; 16:68. https://doi.org/10.1186/s12886-016-0256-7; Cheng C.S., Lee Y.F., Ong C., Yap Z.L., et al. Intereye comparison of retinal oximetry and vessel caliber between eyes with asymmetrical glaucoma severity in different glaucoma subtypes. Clin Ophthalmol 2016; 10:1315-1321. https://doi.org/10.2147/OPTH.S96529.; Jonas J.B., Nangia V., Khare A., Sinha A., et al. Prevalence and associations of retinal vein occlusions: the Central India Eye and Medical Study. Retina 2013; 33:152-159. https://doi.org/10.1097/IAE.0b013e318260246f.; Călugăru D, Călugăru M. Intraocular pressure modifications in patients with acute central/hemicentral retinal vein occlusions. Int J Ophthalmol 2021; 14(6):931-935. https://doi.org/10.18240/ijo.2021.06.20.; Feltgen N., Junker B., Agostini H., Hansen L.L. Retinal endovascular lysis in ischemic central retinal vein occlusion: one-year results of a pilot study. Ophthalmology 2007; 114:716-723. https://doi.org/10.1016/j.ophtha.2006.06.064.; Тульцева С.Н. Использование рекомбинантного тканевого активатора плазминогена в лечении окклюзий вен сетчатки. Офтальмологические ведомости 2010; 3(1):42-50.; Fekrat S., de Juan E Jr. Chorioretinal venous anastomosis for central retinal vein occlusion: transvitreal venipuncture. Ophthalmic Surg Lasers 1999; 30:52-55.; McAllister I.L., Gillies M.E., Smithies L.A., Rochtchina E., et al. The Central Retinal Vein Bypass Study: a trial of laser-induced chorioretinal venous anastomosis for central retinal vein occlusion. Ophthalmology 2010; 117:954-965. https://doi.org/10.1016/j.ophtha.2009.10.026.; Arevalo J.F., Garcia R.A., Wu L., Rodriguez F.J., et al. Radial optic neurotomy for central retinal vein occlusion: results of the Pan-American Collaborative Retina Study Group (PACORES). Retina 2008; 28:1044- 1052. https://doi.org/10.1097/IAE.0b013e3181744153.; Opremcak E.M., Bruce R.A. Surgical decompression of branch retinal vein occlusion via arteriovenous crossing sheathotomy: a prospective review of 15 cases. Retina 1999; 19(1):1-5. https://doi.org/10.1097/00006982-199901000-00001; Campochiaro P.A., Hafiz G., Shah S.M., Nguen Q.D., et al. Ranibizumab for macular edema due to retinal vein occlusions: Impication of VEGF as a critical stimulator. Mol Ther 2008; 16:791-799. https://doi.org/10.1038/mt.2008.10; Campochiaro P.A., Brown D.M., Awh C.C., Lee S.Y., et al. Sustained benefits from ranibizumab for macular edema following central retinal vein occlusion: twelve-month outcomes of a phase III study. Ophthalmology 2011; 118:2041-2049. https://doi.org/10.1016/j.ophtha.2011.02.038.; Pielen A., Clark W.L., Boyer D.S., Ogura Y., et al. Integrated results from the COPERNICUS and GALILEO studies. Clin Ophthalmol 2017; 11:1533-1540. https://doi.org/10.2147/OPTH.S140665; Campochiaro PA, Sophie R, Pearlman J, Brown DM, et al.; RETAIN Study Group. Long-term outcomes in patients with retinal vein occlusion treated with ranibizumab: the RETAIN Study. Ophthalmology 2014; 119(4):802-809. https://doi.org/10.1016/j.ophtha.2013.08.038.; Государственный реестр лекарственных средств. Инструкция по медицинскому применению лекарственного препарата Луцентис ЛСР-004567/08 от 2021 г. Available at: https://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=3fd02ed3-e9fc-4835-97a4-56d19b69227c&t=.; Государственный реестр лекарственных средств. Инструкция по медицинскому применению лекарственного препарата Эйлеа ЛП-003544 от 2020 г. Available at: https://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=9e73411f-469d-4c90-a305-0bb1ec0aefdc&t=.; de Vries V.A., Bassil F.L., Ramdas W.D. The effects of intravitreal injections on intraocular pressure and retinal nerve fiber layer: a systematic review and meta-analysis. Sci Rep 2020; 10:132-148. https://doi.org/10.1038/s41598-020-70269-7.; Noma H., Funatsu H., Mimura T., Eguchi S. Vitreous inflammatory factors and serous retinal detachment in central retinal vein occlusion: a case-control series. J Inflamm (Lond) 2011; 8:38. https://doi.org/10.1186/1476-9255-8-38.; Тульцева С.Н., Астахов Ю.С., Нечипоренко П.А., Овнанян А.Ю. и др. Ранибизумаб и лазерная коагуляция сетчатки в терапии ишемической окклюзии ретинальных вен. Офтальмологические ведомости 2015; 8(2):11-27. https://doi.org/10.17816/OV2015211-27.; Дроздова Е.А., Хохлова Д.Ю., Мезенцева Е.А., Никушкина К.В. Исследование системного и локального уровня цитокинов при окклюзии вен сетчатки на фоне антиангиогенной терапии. Медицинская иммунология 2018; 20(3):365-372. https://doi.org/10.15789/1563-0625-2018-3-365-372.; Государственный реестр лекарственных средств. Инструкция по медицинскому применению лекарственного препарата Озурдекс ЛП-001913 от 2018 г. Available at: https://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=9b03a91d-5af5-40e3-8ede-861465217c81.; Haller J.A., Bandello F., Belfort R. Jr., Blumenkranz M.S., et al. OZURDEX GENEVA Study Group. Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion. Ophthalmology 2010; 117(6):1134- 1146.e3. https://doi.org/10.1016/j.ophtha.2010.03.032.; Capone A. Jr., Singer M.A., Dodwell D.G., Dreyer R.F., et al. Efficacy and safety of two or more dexamethasone intravitreal implant injections for treatment of macular edema related to retinal vein occlusion (Shasta study). Retina 2014; 34(2):342-351. https://doi.org/10.1097/IAE.0b013e318297f842.; Querques L., Querques G., Lattanzio R., Gigante S.R., et al. Repeated intravitreal dexamethasone implant (Ozurdex®) for retinal vein occlusion. Ophthalmologica 2013; 229(1):21-25. https://doi.org/10.1159/000342160.; Hemarat K., Kemmer J.D., Porco T.C., Eaton A.M., et al. Secondary Ocular Hypertension and the Risk of Glaucoma Surgery After Dexamethasone Intravitreal Implant in Routine Clinical Practice. Ophthalmic Surg Lasers Imaging Retina 2018; 49:680-685. https://doi.org/10.3928/23258160-20180831-05.; Malclès A, Dot C, Voirin N, Viè A-L., et al. Safety of intravitreal dexamethasone implant (OZURDEX): The SAFODEX study. Incidence and Risk Factors of Ocular Hypertension. Retina 2017; 37:1352-1359. https://doi.org/10.1097/IAE.0000000000001369.; Hattenbach L.O., Feltgen N., Bertelmann T., Schmitz-Valckenberg S., et al. COMRADE-B Study Group. Head-to-head comparison of ranibizumab PRN versus single-dose dexamethasone for branch retinal vein occlusion (COMRADE-B). Acta Ophthalmol 2018; 96(1):e10-e18. https://doi.org/10.1111/aos.13381.; Feltgen N., Hattenbach L.O., Bertelmann T., Callizo J., et al. Comparison of ranibizumab versus dexamethasone for macular oedema following retinal vein occlusion: 1-year results of the COMRADE extension study. Acta Ophthalmol 2018; 96:e933-e941. https://doi.org/10.1111/aos.13770.; Erfurth-Schmidt U., Garcia-Arumi J., Gerendas B.S., Midena E., et al. Guidelines for the management of retinal vein occlusion by the European Society of retina specialists (EURETINA). Ophthalmologica 2019; 242(3):123-162. https://doi.org/10.1159/000502041.; https://www.glaucomajournal.ru/jour/article/view/536

Διαθεσιμότητα: https://www.glaucomajournal.ru/jour/article/view/536
https://doi.org/10.53432/2078-4104-2024-23-3-54-66

Комбинированное лечение макулярного отёка, развившегося на фоне окклюзии ретинальных вен (клинические примеры) ; Combined treatment of the macular edema due to retinal vein occlusions (clinical examples)

Συγγραφείς: Beresneva, N. S., Bobykin, E. V., Береснева, Н. С., Бобыкин, Е. В.

Πηγή: Сборник статей

Θεματικοί όροι: RETINAL VEIN OCCLUSION, ANTI-VEGF THERAPY, MACULAR EDEMA, INTRAVITREAL INJECTIONS, RETINAL LASER PHOTOCOAGULATION, РЕТИНАЛЬНАЯ ВЕНОЗНАЯ ОККЛЮЗИЯ, АНТИ-VEGF ТЕРАПИЯ, МАКУЛЯРНЫЙ ОТЁК, ИНТРАВИТРЕАЛЬНЫЕ ИНЪЕКЦИИ, ЛАЗЕРНАЯ КОАГУЛЯЦИЯ СЕТЧАТКИ

Περιγραφή αρχείου: application/pdf

Relation: Актуальные вопросы современной медицинской науки и здравоохранения: сборник статей IV Международной научно-практической конференции молодых учёных и студентов, IV Всероссийского форума медицинских и фармацевтических вузов «За качественное образование», (Екатеринбург, 10-12 апреля 2019): в 3-х т. - Екатеринбург: УГМУ, CD-ROM.; http://elib.usma.ru/handle/usma/4134

Διαθεσιμότητα: http://elib.usma.ru/handle/usma/4134

The Role of Steroids in the Management of Macular Edema from Retinal Vein Occlusion ; Роль стероидов в терапии макулярного отека у пациентов с ретинальными венозными окклюзиями

Συγγραφείς: M. V. Budzinskaya, A. V. Shelankova, A. A. Plukhova, N. M. Nuriyeva, A. S. Sorokin, М. В. Будзинская, А. В. Шеланкова, А. А. Плюхова, Н. А. Нуриева, А. С. Сорокин

Πηγή: Ophthalmology in Russia; Том 16, № 1 (2019); 95-101 ; Офтальмология; Том 16, № 1 (2019); 95-101 ; 2500-0845 ; 1816-5095 ; 10.18008/1816-5095-2019-1

Θεματικοί όροι: ранибизумаб, retinal venous occlusion, Ozurdex, ranibizumab, ретинальная венозная окклюзия, имплантат дексаметазона, Озурдекс

Περιγραφή αρχείου: application/pdf

Relation: https://www.ophthalmojournal.com/opht/article/view/863/566; Brown D.M., Campochiaro P.A., Bhisitkul R.B., Ho A.C., Gray S., Saroj N., Adamis A.P., Rubio R.G., Murahashi W.Y. Sustained benefits from ranibizumab for macular edema following branch retinal vein occlusion: 12-month outcomes of a phase III study. Ophthalmology. 2011 Aug; 118(8):1594–602. DOI:10.1016/j.ophtha.2011.02.022; Brown D.M., Campochiaro P.A., Singh R.P., Li Z., Gray S., Saroj N., Rundle A.C., Rubio R.G., Murahashi W.Y.; CRUISE Investigators. Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III study. Ophthalmology. 2010 Jun;117(6):1124–1133.e1. DOI:10.1016/j.ophtha.2010.02.022; Noma H., Minamoto A., Funatsu H., Tsukamoto H., Nakano K., Yamashita H., Mishima H.K. Intravitreal levels of vascular endothelial growth factor and interleukin-6 are correlated with macular edema in branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 244(3):309–315.; McIntosh R.L., Rogers S.L., Lim L., Cheung N., Wang J.J., Mitchell P., Kowalski J.W., Nguyen H.P., Wong T.Y. Natural history of central retinal vein occlusion: an evidence-based systematic review. Review. Ophthalmology. 2010 Jun;117(6):1113–1123.e15. DOI:10.1016/j.ophtha.2010.01.060; Haller J.A., Bandello F., Belfort R. Jr, Blumenkranz M.S., Gillies M., Heier J., Loewenstein A., Yoon Y.H., Jacques M.L., Jiao J., Li X.Y., Whitcup S.M.; OZURDEX GENEVA Study Group. Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion. Ophthalmology. 2010 Jun;117(6):1134–1146.e3. DOI:10.1016/j.ophtha.2010.03.032; Berthon L., Laurent Ch., Tanguy R., Sibille-Dabadie B., Philippe-Zech K., Wolff B. Long-term use of Ozurdex® in macular oedema from retinal vein occlusions. CERK/RVO Study. Les Cahiers d’Ophthalmologie. 2013;15:25–27.; Korobelnik J.F., Kodjikian L., Delcourt C. Two-year, prospective, multicenter study of the use of dexamethasone intravitreal implant for treatment of macular edema secondary to retinal vein occlusion in the clinical setting in France. Graefes Arch Clin Exp Ophthalmol. 2016;254:2307–2318. DOI: https://doi.org/10.1007/s00417-016-3394-y; Pommier S. Long-Term Real-Life Efficacy and Safety of Repeated Ozurdex® Injections and Factors Associated with Macular Edema Resolution after Retinal Vein Occlusion: The REMIDO 2 Study. Ophthalmologica. 2016;236:186–192. DOI:10.1159/000452896; Yeh W.S., Haller J.A., Lanzetta P., Kuppermann B.D., Wong T.Y., Mitchell P., Whitcup S.M., Kowalski J.W. Effect of the duration of macular edema on clinical outcomes in retinal vein occlusion treated with dexamethasone intravitreal implant. Ophthalmology. 2012 Jun;119(6):1190–1198. DOI:10.1016/j.ophtha.2011.12.028; Yoon Y.H., Kim J.W., Lee J.Y., Kim I.T., Kang S.W., Yu H.G., Koh H.J., Kim S.S., Chang D.J., Simonyi S. Dexamethasone Intravitreal Implant for Early Treatment and Retreatment of Macular Edema Related to Branch Retinal Vein Occlusion: The Multicenter COBALT Study. Ophthalmologica. 2018;240(2):81–89. DOI:10.1159/000487547; https://www.ophthalmojournal.com/opht/article/view/863

Διαθεσιμότητα: https://www.ophthalmojournal.com/opht/article/view/863
https://doi.org/10.18008/1816-5095-2019-1-95-101